Taxifolin as a novel antimetastatic agent for lung adenocarcinoma: A network pharmacology and experimental validation
Electronic Journal of Biotechnology · 2026-11 · 84 · 100735
DOI: 10.1016/j.ejbt.2026.100735 ↗Kurz gefasst
Fachartikel in der Zeitschrift Electronic Journal of Biotechnology, 2026-11. Verfasst von Xiao Jiang und 5 weiteren Autor:innen. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Yunnan Provincial Department of Education Science Research Fund Project.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Yunnan Provincial Department of Education Science Research Fund Project
Zitieren
APA
Jiang, X., Li, L., Wei, T., Deng, Y., Chang, L., & Li, W. (2026). Taxifolin as a novel antimetastatic agent for lung adenocarcinoma: A network pharmacology and experimental validation. Electronic Journal of Biotechnology, 84, 100735. https://doi.org/10.1016/j.ejbt.2026.100735
Vancouver
Jiang X, Li L, Wei T, Deng Y, Chang L, Li W. Taxifolin as a novel antimetastatic agent for lung adenocarcinoma: A network pharmacology and experimental validation. Electronic Journal of Biotechnology. 2026;84:100735. doi:10.1016/j.ejbt.2026.100735
BibTeX
@article{Jiang2026,
author = {Jiang, Xiao and Li, Lan and Wei, Tao and Deng, Yu and Chang, Li and Li, Wenhui},
title = {Taxifolin as a novel antimetastatic agent for lung adenocarcinoma: A network pharmacology and experimental validation},
journal = {Electronic Journal of Biotechnology},
year = {2026},
volume = {84},
pages = {100735},
doi = {10.1016/j.ejbt.2026.100735}
}
EUVIMED